Shanghai CEO Conference

Mar 28, 2012
The Peninsula Shanghai
32 Zhongshan Dong Yi Road
Shanghai, China

Cost: $1950 per person
Dress Code: Business Attire

To reserve your hotel room at the Peninsula Shanghai, please contact Iris Chen via (86-21) 2327 2888 EXT: 7626 or (86-21) 2327 6588 (RSVN direct line). Please let them know you are with the “Shanghai CEO Conference”.

Agenda – Agenda

Time Agenda
March 28, 2012
4:00 - 4:30 pm Registration
4:30 - 4:45 pm Welcome and Opening Co-Host Remarks
Paul Bolno, GlaxoSmithKline; Nancy Chang, OrbiMed; Chun-lin Chen, Medicilon; Li Chen, Hua Medicine; Michelle Dipp, OvaScience; Samantha Du, Ge Li, WuXi Pharma; Joel Marcus, Alexandria Real Estate; Paul Schimmel, Scripps; Goro Takeda, Sofinnova Ventures; Christoph Westphal, Verastem; Steve Yang, Astrazeneca; Jingwu Zang, GlaxoSmithKline
4:45 - 5:15 pm Opportunities and Challenges in China
Richard Sackler, Chairman & Owner, Purdue Pharma
Moderator: Ge Li, WuXi Pharma
5:15 - 5:45 pm How Healthcare Innovation is Transforming Asia
John Oyler, Beigene; Paul Schimmel, Scripps Research Institute
5:45 - 6:15 pm Lifetime Achievement Award
Nominees: Chun-Lin Chen, Medicilon; Ge Li, WuXi Pharma
6:15 - 7:15 pm Networking Cocktails and Hors d’oeuvres
Co-hosted by: Paul Bolno, GlaxoSmithKline; Nancy Chang, OrbiMed; Chun-lin Chen, Medicilon; Li Chen, Hua Medicine; Michelle Dipp, OvaScience; Samantha Du, Ge Li, WuXi Pharma; Joel Marcus, Alexandria Real Estate; Paul Schimmel, Scripps; Goro Takeda, Sofinnova Ventures; Christoph Westphal, Verastem; Steve Yang, Astrazeneca; Jingwu Zang, GlaxoSmithKline
March 29, 2012
7:00 - 7:45 am Registration and Networking Breakfast
7:45 - 8:30 am Welcome and Opening Remarks
8:30 - 9:15 am Healthcare Investor Perspective
Modassir Choudhry, Passport Capital; Francesco De Rubertis, Index Ventures; Steve Knight, Fidelity; Thomas Roberts, Farallon Capital Management
Moderator: Arthur Mok, Ropes & Gray, LLP
9:15 - 10:00 am Business Development
Tao Fu, Johnson & Johnson; Shaun Grady, Astrazeneca; Joe McCracken, Roche; David Nicholson, Merck
Moderator: Samantha Du
10:00 - 10:30 am Networking Break
10:30 - 11:15 am Biotech R&D
Luc Dochez, Prosensa Therapeutics; Carl Firth, ASLAN Pharmaceuticals; Robert Gould, Epizyme; Frank Jiang, Sanofi-Aventis; Mathai Mammen, Theravance; Jason Mann, Barclays Capital; Sam Waksal, Kadmon Corp.
Moderator: Michelle Dipp, OvaScience
11:15 - 12:00 pm Partnering Between US/China
Paul Bolno, GlaxoSmithKline; Chun-Lin Chen, Medicilon; Art Pappas, Pappas Ventures
Moderator: Joel Marcus, Alexandria Real Estate Equities
12:00 - 1:00 pm Networking Lunch
1:00 - 1:45 pm US Biotech CEO
Stephen Collins, Neurotherapeutics Pharma; Oliver Fetzer, Cerulean Pharma; Lonnie Moulder, Tesaro; Chris Varma, Blueprint Medicines
Moderator: Marc Grasso, UBS
1:45 - 2:30 pm Venture Capital
Rich Aldrich, Longwood Fund; Nancy Chang, OrbiMed; Taro Inaba, Mitsui & Co.; Robert Nelsen, Arch Venture; Yi Shi, Lilly Asia Ventures; Goro Takeda, Sofinnova Ventures; Shinya Yano, Astellas Venture Management; Peter Zhang, IDG Capital Partners
Moderator: Christoph Westphal, Verastem
2:30 - 3:00 pm Networking Break
3:00 - 3:45 pm Legal, IP, Licensing and Partnership
Tom Irving, Partner, Finnegan, LLP, ; Marc Rubenstein, Partner, Ropes & Gray, LLP
3:45 - 4:30 pm Pharmaceutical R&D
Li Chen, Hua Medicine; Ruiping Dong, Merck; Steve Yang, AstraZeneca; Jingwu Zang, GlaxoSmithKline
Moderator: Ge Li, WuXi Pharma
4:30 - 5:30 pm Networking Cocktails and Hors d’oeuvres
Co-hosted by: Paul Bolno, GlaxoSmithKline; Nancy Chang, OrbiMed; Chun-lin Chen, Medicilon; Li Chen, Hua Medicine; Michelle Dipp, OvaScience; Samantha Du, Ge Li, WuXi Pharma; Joel Marcus, Alexandria Real Estate; Paul Schimmel, Scripps; Goro Takeda, Sofinnova Ventures; Christoph Westphal, Verastem; Steve Yang, Astrazeneca; Jingwu Zang, GlaxoSmithKline

Hotels

Name Address Phone
Peninsula Shanghai 32 Zhongshan Dong Yi Road, Shanghai, China

Co-Hosts

Name Company
Paul Bolno GlaxoSmithKline
Nancy Chang OrbiMed
Chun-Lin Chen Medicilon
Li Chen Hua Medicine
Michelle Dipp OvaScience
Samantha Du
Robert Forrester Verastem
Ge Li WuXi PharmaTech
Joel Marcus Alexandria Real Estate Equities
Robert Nelsen ARCH Venture Partners
Paul Schimmel Scripps
Goro Takeda Sofinnova Ventures
Christoph Westphal Verastem
Steve Yang Astrazeneca
Jingwu Zang GlaxoSmithKline